Known targets — ChEMBL curated mechanism
PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Tryptophan. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 17/20 | 0.41 |
| ▸ | CCKBR | P32239 | 2/20 | 0.39 |
| ▸ | CALCR | P30988 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tryptophan SCHEMBL6479239 | 0.98 | GLP1R (0.41) | GLP1RCCKBRCALCR | |
| Tryptophan SCHEMBL6563945 | 0.98 | GLP1R (0.41) | GLP1R | |
| Tryptophan SCHEMBL6438435 | 0.97 | GLP1R (0.40) | GLP1R | |
| Tryptophan SCHEMBL28943517 | 0.97 | PTH1R (0.38) | GLP1RCCKBRCALCR | |
| Tryptophan SCHEMBL27505901 | 0.94 | GLP1R (0.45) | GLP1RCCKBR | |
| Tryptophan SCHEMBL27700472 | 0.94 | GLP1R (0.45) | GLP1RCCKBR | |
| Tryptophan SCHEMBL27646591 | 0.94 | GLP1R (0.45) | GLP1RCCKBR | |
| Tryptophan SCHEMBL27448344 | 0.94 | GLP1R (0.44) | GLP1RCCKBR | |
| Tryptophan SCHEMBL27645885 | 0.94 | GLP1R (0.44) | GLP1RCCKBR | |
| Tryptophan SCHEMBL27331432 | 0.93 | GLP1R (0.45) | GLP1RCCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101084304-A | Peptide compositions for promoting growth and synthesis of a specified product in cell and/or tissue culture | PF MEDICAMENT (FR) | 2007-12-05 | — | — | CN | claimed |
| EP-1562579-A1 | THERAPEUTIC DELIVERY OF CARBON MONOXIDE | Hemocorm Limited (GB) | 2005-08-17 | — | — | EP | claimed |
| WO-2004045599-A1 | THERAPEUTIC DELIVERY OF CARBON MONOXIDE | HEMOCORM LIMITED (GB) | 2004-06-03 | — | — | WO | claimed |
| CN-101084304-A | Peptide compositions for promoting growth and synthesis of a specified product in cell and/or tissue culture | PF MEDICAMENT (FR) | 2007-12-05 | — | — | CN | disclosed |